FRONT COVER -- THE ECONOMICS OF MEDICAL TECHNOLOGY -- COPYRIGHT PAGE -- CONTENTS -- LIST OF CONTRIBUTORS -- OVERVIEW -- ASPECTS OF RESEARCH AND DEVELOPMENT CONTRACT TERMS IN THE BIO/PHARMACEUTICAL SECTOR -- INTRODUCTION -- DESCRIPTION OF THE PROBLEM -- CONSTRUCTION OF HYPOTHESES -- EMPIRICAL ANALYSIS -- CONCLUSION -- NOTES -- ACKNOWLEDGMENTS -- REFERENCES -- EFFECTS OF REGULATION ON DRUG LAUNCH AND PRICING IN INTERDEPENDENT MARKETS -- INTRODUCTION -- LITERATURE -- PHARMACEUTICAL PRICE REGULATION AND ITS MEASUREMENT -- THEORETICAL MODEL AND EMPIRICAL SPECIFICATION -- DATA AND VARIABLE DEFINITIONS -- DESCRIPTIVES -- DETERMINANTS OF LAUNCH -- DETERMINANTS OF LAUNCH PRICE -- CONCLUSIONS -- NOTES -- ACKNOWLEDGMENTS -- REFERENCES -- THE EFFECT OF PHARMACEUTICAL INNOVATION ON THE FUNCTIONAL LIMITATIONS OF ELDERLY AMERICANS: EVIDENCE FROM THE 2004 NATIONAL NURSING HOME SURVEY -- INTRODUCTION -- MEASUREMENT -- EMPIRICAL RESULTS -- SUMMARY AND CONCLUSIONS -- NOTES -- ACKNOWLEDGMENTS -- REFERENCES -- COMPARATIVE EFFECTIVENESS RESEARCH, TECHNOLOGICAL ABANDONMENT, AND HEALTH CARE SPENDING -- INTRODUCTION -- COMPARATIVE EFFECTIVENESS RESEARCH AND COSTS -- A MODEL OF ADOPTION AND ABANDONMENT -- CASE STUDIES OF ABANDONMENT -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- HOW DO INITIAL SIGNALS OF QUALITY INFLUENCE THE DIFFUSION OF NEW MEDICAL PRODUCTS? THE CASE OF NEW CANCER DRUG TREATMENTS -- INTRODUCTION -- A BRIEF REVIEW OF CONTEMPORARY CANCER TREATMENT -- EMPIRICAL METHODS -- RESULTS -- DISCUSSION -- NOTES -- ACKNOWLEDGMENTS -- REFERENCES -- TECHNOLOGY DIFFUSION AND SUBSTITUTION OF MEDICAL INNOVATIONS -- INTRODUCTION -- BACKGROUND -- HYPOTHESES AND EMPIRICAL SPECIFICATION -- DATA -- EMPIRICAL STRATEGY -- RESULTS -- CONCLUDING REMARKS -- NOTES -- REFERENCES -- HEALTH INSURANCE AND HOSPITAL TECHNOLOGY ADOPTION -- INTRODUCTION.

THEORY ON THE LINK BETWEEN INSURANCE COVERAGE AND TECHNOLOGY ADOPTION -- EMPIRICAL EVIDENCE ON THE EXTENT OF COVERAGE -- EMPIRICAL EVIDENCE ON THE PARAMETERS OF INSURANCE CONTRACTS -- EVIDENCE FROM PREVIOUS MEDICAID EXPANSIONS -- POTENTIAL IMPLICATIONS OF THE AFFORDABLE CARE ACT -- NOTES -- ACKNOWLEDGMENTS -- REFERENCES.